🔴 Senti Biosciences is trading 5.6% down today amid broader biotech weakness

Senti Biosciences is trading 5.6% down at $0.34 today as the broader biotech sector faces significant selling pressure.

• The move gives back part of the prior day’s bounce following a multi-day slide, with no new company-specific news or filings driving the price action.
• The decline aligns with continued weakness in the biotech space, where the XBI ETF is down over 3%.
• Broader market flows are currently favoring larger, higher-quality names over small-cap biotech stocks.